New research emerges In the ever-evolving landscape of psychedelic-assisted therapy, a new scientific review sheds light on the safety profile of psychedelics for individuals grappling with epilepsy. Researchers determined 11 papers that met the inclusion criteria and from there, meticulously analyzed any data regarding the type of psychedelic used, the context of their use, and the outcomes related to seizure activity. - The scientific review Researchers reviewed a variety of substances, from classical psychedelics like LSD and psilocybin, known for their serotonergic system effects, to atypical ones such as MDMA and ketamine, offering insights into their potential impacts on seizure susceptibility. - The results The review found that these substances are there is no direct link between psychedelic use and the induction of seizures, suggesting that psychedelics may be safe for individuals with epilepsy when used under medical supervision. - Quotable “It should be noted, however, that in all reports of psychedelic use while under clinical supervision, such as Argento et al. (2023) and Serafetinides (1965), no significant serious adverse events were reported in the individuals who have epilepsy.”